Used in pharmaceutical research as a potent inhibitor in targeted cancer therapies, particularly in the development of kinase inhibitors. Shows promising activity against tumor cell proliferation by selectively interfering with signaling pathways involved in cancer progression. Its structure enables high binding affinity to specific protein targets, enhancing efficacy in preclinical models of solid tumors. Also utilized in structure-activity relationship (SAR) studies to optimize drug candidates for improved metabolic stability and bioavailability.